Coherence Neuro
Cambridge
About Coherence Neuro
Coherence specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics, Coherence is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $12.3M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: coherenceneuro.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/coherence-neuro-104918 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.